Literature DB >> 25424699

Novel mutations in the RB1 gene from Chinese families with a history of retinoblastoma.

Leilei Zhang1, Renbing Jia, Junyang Zhao, Jiayan Fan, YiXiong Zhou, Bing Han, Xin Song, Li Wu, He Zhang, Huaidong Song, Shengfang Ge, Xianqun Fan.   

Abstract

Retinoblastoma is an aggressive eye cancer that develops during infancy and is divided into two clinical types, sporadic and heritable. RB1 has been identified as the only pathological gene responsible for heritable retinoblastoma. Here, we identified 11 RB1 germline mutations in the Han pedigrees of 17 bilateral retinoblastoma patients from China. Four mutations were nonsense mutations, five were splice site mutations, and two resulted in a frame shift due to an insertion or a deletion. Three of the mutations had not been previously reported, and the p.Q344L mutation occurred in two generations of retinoblastoma patients. We investigated phenotypic-genotypic relationships for the novel mutations and showed that these mutations affected the expression, location, and function of the retinoblastoma protein. Abnormal protein localization was observed after transfection of the mutant genes. In addition, changes in the cell cycle distribution and apoptosis rates were observed when the Saos-2 cell line was transfected with plasmids encoding the mutant RB1 genes. Our findings expand the spectrum of known RB1 mutations and will benefit the investigation of RB1 mutation hotspots. Genetic counseling can be offered to families with heritable RB1 mutations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25424699     DOI: 10.1007/s13277-014-2851-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  41 in total

1.  Identification of a growth suppression domain within the retinoblastoma gene product.

Authors:  X Q Qin; T Chittenden; D M Livingston; W G Kaelin
Journal:  Genes Dev       Date:  1992-06       Impact factor: 11.361

2.  National Retinoblastoma Strategy Canadian Guidelines for Care: Stratégie thérapeutique du rétinoblastome guide clinique canadien.

Authors: 
Journal:  Can J Ophthalmol       Date:  2009       Impact factor: 1.882

Review 3.  The regulation of E2F by pRB-family proteins.

Authors:  N Dyson
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

4.  Preimplantation genetic diagnosis for neurofibromatosis type 1.

Authors:  C Spits; M De Rycke; N Van Ranst; H Joris; W Verpoest; W Lissens; P Devroey; A Van Steirteghem; I Liebaers; K Sermon
Journal:  Mol Hum Reprod       Date:  2005-04-15       Impact factor: 4.025

5.  Clinical presentation and group classification of newly diagnosed intraocular retinoblastoma in China.

Authors:  Junyang Zhao; Songfeng Li; Jitong Shi; Ningli Wang
Journal:  Br J Ophthalmol       Date:  2011-01-20       Impact factor: 4.638

6.  Preimplantation genetic diagnosis of inherited cancer: familial adenomatous polyposis coli.

Authors:  A Ao; D Wells; A H Handyside; R M Winston; J D Delhanty
Journal:  J Assist Reprod Genet       Date:  1998-03       Impact factor: 3.412

7.  The retinoblastoma protein regulates pericentric heterochromatin.

Authors:  Christian E Isaac; Sarah M Francis; Alison L Martens; Lisa M Julian; Laurie A Seifried; Natalie Erdmann; Ulrich K Binné; Lea Harrington; Piotr Sicinski; Nathalie G Bérubé; Nicholas J Dyson; Frederick A Dick
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

8.  Frequent constitutional C to T mutations in CGA-arginine codons in the RB1 gene produce premature stop codons in patients with bilateral (hereditary) retinoblastoma.

Authors:  J K Cowell; T Smith; B Bia
Journal:  Eur J Hum Genet       Date:  1994       Impact factor: 4.246

9.  Detection of mosaic RB1 mutations in families with retinoblastoma.

Authors:  Diane Rushlow; Beata Piovesan; Katherine Zhang; Nadia L Prigoda-Lee; Mellone N Marchong; Robin D Clark; Brenda L Gallie
Journal:  Hum Mutat       Date:  2009-05       Impact factor: 4.878

10.  RB1 gene mutations in retinoblastoma and its clinical correlation.

Authors:  Mohammad Javed Ali; Vidya Latha Parsam; Santosh G Honavar; Chitra Kannabiran; Geeta K Vemuganti; Vijay Anand P Reddy
Journal:  Saudi J Ophthalmol       Date:  2010-02-06
View more
  4 in total

1.  Study of Cinobufagin as a Promising Anticancer Agent in Uveal Melanoma Through Intrinsic Apoptosis Pathway.

Authors:  Leilei Zhang; Xiaolin Huang; Tao Guo; Huixue Wang; Haiyan Fan; Li Fang
Journal:  Front Oncol       Date:  2020-04-02       Impact factor: 6.244

2.  Retinoblastoma genetics screening and clinical management.

Authors:  Himika Gupta; Sivasankar Malaichamy; Ashwin Mallipatna; Sakthivel Murugan; Nallathambi Jeyabalan; Vishnu Suresh Babu; Anuprita Ghosh; Arkasubhra Ghosh; Sam Santhosh; Somasekar Seshagiri; Vedam L Ramprasad; Govindasamy Kumaramanickavel
Journal:  BMC Med Genomics       Date:  2021-07-22       Impact factor: 3.063

3.  Novel FOXC2 Mutation in Hereditary Distichiasis Impairs DNA-Binding Activity and Transcriptional Activation.

Authors:  Leilei Zhang; Jie He; Bing Han; Linna Lu; Jiayan Fan; He Zhang; Shengfang Ge; Yixiong Zhou; Renbing Jia; Xianqun Fan
Journal:  Int J Biol Sci       Date:  2016-08-06       Impact factor: 6.580

4.  Mutation spectrum of RB1 mutations in retinoblastoma cases from Singapore with implications for genetic management and counselling.

Authors:  Swati Tomar; Raman Sethi; Gangadhara Sundar; Thuan Chong Quah; Boon Long Quah; Poh San Lai
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.